BIOMAT Database Logo BIOMAT Database Logo

[Untoward effects of low dose methotrexate therapy in rheumatoid arthritis]. 1996

Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine.

Sixty patients with rheumatoid arthritis who were administered weekly low dose methotrexate (MTX) were retrospectively analyzed for their untoward effects of MTX by interviewing to the patients and by the medical records. Cough and sputa were the most frequent symptoms (23.3%) and gastrointestinal symptoms were the next (20%). Five of 60 patients (8.2%) showed liver function test abnormalities, and four (6.7%) exhibited transient exacerbation of arthralgia for several hours to a few days after MTX administration. Three patients (5%) suffered from interstitial pneumonitis. Hair loss was seen in 3 patients (5%), and headache, leucocytepenia, fever, skin eruption, abnormal taste, hemorrhagic cystitis, and flashing were experienced in a patient, respectively. Three (5%) suffered from fungal infection, and herpes zoster, sepsis, and osteomyelitis were experienced in each one patient, respectively. MTX was withdrawn in three patients (5%) because of cough and sputa the drug was withdrawn in other three patients because of the interstitial pneumonia, and was drawn in another three patients because of transient exacerbation of arthralgia. The drug was withdrawn in each one patient, because of nausea and vomiting, skin eruption, osteomyelitis, and sepsis, respectively. Overall, MTX were withdrawn in 21 patients (35%), and, of those, 13 patients (21.7%) because of untoward effects and 8 patients (13.3%) because of the lack of efficacy.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003371 Cough A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs. Coughs
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005260 Female Females
D006261 Headache The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS. Cephalgia,Hemicrania,Bilateral Headache,Cephalalgia,Cephalodynia,Cranial Pain,Generalized Headache,Head Pain,Ocular Headache,Orthostatic Headache,Periorbital Headache,Retro-Ocular Headache,Sharp Headache,Throbbing Headache,Unilateral Headache,Vertex Headache,Bilateral Headaches,Cephalalgias,Cephalgias,Cephalodynias,Cranial Pains,Generalized Headaches,Head Pains,Headache, Bilateral,Headache, Generalized,Headache, Ocular,Headache, Orthostatic,Headache, Periorbital,Headache, Retro-Ocular,Headache, Sharp,Headache, Throbbing,Headache, Unilateral,Headache, Vertex,Headaches,Headaches, Bilateral,Headaches, Generalized,Headaches, Ocular,Headaches, Orthostatic,Headaches, Periorbital,Headaches, Retro-Ocular,Headaches, Sharp,Headaches, Throbbing,Headaches, Unilateral,Headaches, Vertex,Ocular Headaches,Orthostatic Headaches,Pain, Cranial,Pain, Head,Pains, Cranial,Pains, Head,Periorbital Headaches,Retro Ocular Headache,Retro-Ocular Headaches,Sharp Headaches,Throbbing Headaches,Unilateral Headaches,Vertex Headaches
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
November 1993, The Journal of rheumatology,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
[Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis].
October 1996, Ryumachi. [Rheumatism],
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
[Low dose methotrexate therapy in rheumatoid arthritis].
June 1990, Ryumachi. [Rheumatism],
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Low dose pulse methotrexate therapy in rheumatoid arthritis.
January 1980, The Journal of rheumatology,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Renal effects of low dose methotrexate in rheumatoid arthritis.
July 1993, The Journal of rheumatology,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis.
November 1985, Archives of internal medicine,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Low dose methotrexate in rheumatoid arthritis.
January 1982, The Journal of rheumatology,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis.
June 1993, Clinical rheumatology,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
[Low-dose methotrexate therapy of rheumatoid arthritis in the elderly].
May 1995, Orvosi hetilap,
Y Kawabe, and K Eguchi, and M Tsuboi, and M Kita, and T Tsukada, and H Takashima, and A Mizokami, and A Kawakami, and N Matsuoka, and K Migita, and S Nagataki
Gynecomastia following low dose methotrexate therapy for rheumatoid arthritis.
April 1995, The Journal of rheumatology,
Copied contents to your clipboard!